HOME >> MEDICINE >> NEWS
USC/Norris Study Finds No Benefit Of Finasteride In Preventing Prostate Cancer In Men At Elevated Risk


Study Suggests That Drug Could Leave Certain Men At Higher Risk

LOS ANGELES, Calif., Aug. 1, 1998 -- A new study by USC/Norris Cancer Center scientists raises serious questions about the potential use of the drug finasteride to prevent prostate cancer.

Scientists have theorized that finasteride, sold under the brand name Proscar and commonly used to treat benign prostate disease, might offer men a way to cut their risk of developing prostate cancer.

Yet, "it appears that finasteride may not be effective as a chemopreventive agent against prostate cancer, at least in men with high PSA levels," says Ronald K. Ross, M.D., USC professor of preventive medicine and deputy director of the USC/Norris Cancer Center.

"There may even be a subgroup of patients in whom the drug actually could be harmful," says co-author Richard J. Cote, M.D., USC associate professor of pathology and urology. Ross and Cote, along with Eila C. Skinner, M.D., USC associate professor of urology, led the study, which appears in the first August issue of the British Journal of Cancer.

Prostate cancer is the most frequently diagnosed cancer in the United States, and proves fatal for some 40,000 men each year. At present, there's no proven way to prevent the disease.

USC/Norris researchers have long led research on the role of the male hormones androgens in spurring prostate cancer growth. Ross and his colleagues first proposed that lowering levels of the androgen most active in the prostate, called dihydrotestosterone (DHT), could possibly prevent prostate cancer. Ross' team was also the first to suggest that finasteride, which lowers the levels of DHT by blocking the enzyme that converts testosterone into DHT, might prevent the formation of prostate cancer.

The National Cancer Institute (NCI) is in the midst of a large national clinical trial to determine if finasteride can reduce the incidence of prostate cancer. The seven-year NCI study has
'"/>

Contact: Eva Emerson or Brenda Maceo
eemerson@hsc.usc.edu
323-442-2830
University of Southern California
1-Aug-1998


Page: 1 2 3 4

Related medicine news :

1. USC/Norris oncologists test new front-line therapy for pancreatic cancer
2. Study of energy and health in Africa focuses spotlight on charcoal and forest management
3. Study shows promise in identifying kidney failure
4. Study shows patch therapy may be as effective as oral medications
5. Study shows soy is well accepted in school lunches
6. Study finds that coordinating care of chronically ill patients does not increase liability
7. Study provides new estimates of the causes of child mortality worldwide
8. Study finds factors linked to substance use disorder relapse among health care professionals
9. Study finds majority of women willing to accept cervical cancer vaccine for self and children
10. Study shows use of budesonide reduced the risk of asthma related events by 40% in children
11. Study shows risk of cardiac death after radiation for breast cancer has dramatically decreased

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:11/30/2019)... ... November 29, 2019 , ... ... and honored customs, teachers aren’t focusing on the potential for academic backslide but ... picking up their textbooks or logging into GoogleClassroom as often during the break ...
(Date:11/27/2019)... (PRWEB) , ... November 27, 2019 , ... AltMed ... (source: OMMU), has announced the grand opening of its newest MÜV™ Medical ... Florida Avenue in Lakeland. , AltMed’s eleventh MÜV Dispensary in Florida, is located on ...
(Date:11/23/2019)... (PRWEB) , ... November 22, 2019 , ... AIS ... Health Awards® program. This competition — held each spring and fall — recognizes the ... Website received a Silver Award in the category of Web-Based Digital Health/Responsive Website ...
(Date:11/22/2019)... SAN DIEGO (PRWEB) , ... November 22, 2019 ... ... organization, and GE Healthcare, a leading provider of medical imaging, monitoring, biomanufacturing, and ... and to help save lives. As part of this relationship, GE Healthcare is ...
(Date:11/22/2019)... ... ... Acclaimed actor from “The Matrix,” “Contagion,” and “Mystic River,” Laurence Fishburne, is also ... teaching tool for its viewing audience and covers a wide variety of topics affecting ... on a journey into the world of medical technology. The upcoming episode will showcase ...
Breaking Medicine News(10 mins):
(Date:11/30/2019)... ... November 28, 2019 , ... Craig Wallentine, Global Business ... of the board of trustees of the International Safety Equipment Association ... CEO, Ergodyne , was elected vice chairman. , Nate Kogler, Senior Director ...
(Date:11/30/2019)... ... 2019 , ... In the United States, we regard chefs as a talented ... is no shortage of phenomenal restaurants for guests to visit. Meet the chef behind ... Christian Bowman, Chef to NBA All-Stars and celebrities, is a culinary master with raw ...
(Date:11/27/2019)... ... November 27, 2019 , ... Chris Draft faced some tough opponents ... he and girlfriend, Keasha, received when Keasha, a never-smoker, was diagnosed with lung cancer. ... 8 years ago today, standing hand-in-hand, they launched Team Draft, as part of the ...
Breaking Medicine Technology:
Cached News: